Last updated on June 2019

Study of Anlotinib in Patients With Esophageal Squamous Cell Carcinoma (ALTER1102)


Brief description of study

To compare the effects and safety of Anlotinib with placebo in patients with esophageal squamous cell carcinoma(ESCC).

Clinical Study Identifier: NCT02649361

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.